Docosanol

Description

Docosanol Cream, 10%, is a topical formulation indicated for the treatment of cold sores and fever blisters. This cream is the only over-the-counter (OTC) medication approved by the FDA for the purpose of shortening the healing time and duration of symptoms associated with these conditions. Each tube contains a net weight of 2 grams (0.07 ounces) of the active ingredient, docosanol, which is formulated to provide effective relief.

Uses and Indications

This drug is indicated for the treatment of cold sores and fever blisters on the face or lips. It is the only FDA-approved medication that shortens the healing time and reduces the duration of associated symptoms, including tingling, pain, burning, and/or itching.

Limitations of Use: This medication is specifically indicated for the management of cold sores and is not intended for other types of herpes infections or for use in immunocompromised patients unless directed by a healthcare professional.

Dosage and Administration

Adults and children aged 12 years or over should wash their hands thoroughly before and after applying the cream. The cream should be applied to the affected area on the face or lips at the first sign of a cold sore or fever blister, such as a tingling sensation. Early treatment is essential for optimal results. The cream must be rubbed in gently but completely. It is recommended to apply the cream five times a day until the lesion is healed.

For children under 12 years of age, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with a known allergy to any ingredient in this product should not use it due to the risk of allergic reactions. Additionally, the product should not be applied in or near the eyes, nor should it be applied directly inside the mouth. Sharing this product is also contraindicated, as it may facilitate the spread of infection.

Warnings and Precautions

This product has the potential to induce severe allergic reactions. Healthcare professionals should be vigilant for symptoms such as hives, facial swelling, wheezing or difficulty breathing, shock, and rash. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

This product is intended for external use only. Ingestion of the product necessitates prompt medical attention; individuals should contact a Poison Control Center or seek medical help without delay.

It is crucial to avoid use in patients with known allergies to any ingredient contained in this product. Additionally, if a patient's cold sore worsens or does not show signs of healing within 10 days, it is advised to discontinue use and consult a physician for further evaluation and management.

Side Effects

Patients may experience a severe allergic reaction to this product, which can manifest as hives, facial swelling, wheezing or difficulty breathing, shock, and rash. It is crucial for patients to be aware of these symptoms and seek immediate medical attention if they occur.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if their cold sore worsens or does not heal within 10 days. This recommendation is based on observations that prolonged or worsening symptoms may require further evaluation and management.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Docosanol. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before using this medication. For adolescents and adults aged 12 years and older, it is recommended to wash hands before and after applying the cream. The cream should be applied to the affected area on the face or lips at the first sign of a cold sore or fever blister (tingle). Early treatment is essential for optimal results. The cream should be gently rubbed in completely and used five times a day until healing is achieved.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

This product has not been studied in pregnant women, and safety during pregnancy has not been established. Therefore, use during pregnancy is not recommended. Healthcare professionals should consider the potential risks and benefits when prescribing this product to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of Docosanol Cream in lactating mothers. Additionally, the insert does not provide any specific considerations or precautions related to lactation or breastfeeding. Therefore, healthcare professionals may consider the use of this medication in nursing mothers without special concerns.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide management decisions and ensure optimal patient care.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is essential to inform patients not to use the product if they have a known allergy to any of its ingredients.

Patients should be instructed to discontinue use and consult a doctor if their cold sore worsens or does not heal within 10 days. When using the product, patients must apply it only to the affected areas and should be cautioned against using it in or near the eyes. Additionally, they should avoid applying the product directly inside the mouth.

Healthcare providers should emphasize the importance of not sharing this product with others, as this may facilitate the spread of the infection.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). Care must be taken to ensure that the product does not freeze, as this may compromise its integrity and effectiveness. Proper storage conditions are essential to maintain the quality of the product throughout its shelf life.

Additional Clinical Information

The product is administered topically, applied to the affected area on the face or lips at the first sign of a cold sore or fever blister (tingle). Patients should use the treatment five times a day until the lesion is healed.

Clinicians should counsel patients to discontinue use and seek medical attention immediately if an allergic reaction occurs. Additionally, patients are advised to stop use and consult a doctor if the cold sore worsens or does not heal within 10 days. It is important to keep the product out of reach of children, and in the event of ingestion, medical help or contact with a Poison Control Center should be sought promptly.

Drug Information (PDF)

This file contains official product information for Docosanol, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)